Effect of AST-120 on endothelial dysfunction in adenine-induced uremic rats

International Journal of Nephrology

Volumn 2014, Issue , 2014, Pages

  Inami, Yuko ^a   Hamada, Chieko ^a   Seto, Takuya ^a   Hotta, Yoko ^a   Aruga, Seiki ^a   Inuma, Jiro ^a   Azuma, Kosuke ^a   Io, Hiroaki ^a   Kaneko, Kayo ^a   Watada, Hirotaka ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899996881     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2014/164125     Document Type: Article

References (28)

1. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C.-Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. The New England Journal of Medicine 2004 351 13 1296 1370 2-s2.0-4644221457 10.1056/NEJMoa041031
2. Sarnak M. J., Levey A. S., Schoolwerth A. C., Coresh J., Culleton B., Hamm L. L., McCullough P. A., Kasiske B. L., Kelepouris E., Klag M. J., Parfrey P., Pfeffer M., Raij L., Spinosa D. J., Wilson P. W., Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003 108 17 2154 2169 2-s2.0-0141468244 10.1161/01.CIR.0000095676. 90936.80
3. Ritz E., McClellan W. M., Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. Journal of the American Society of Nephrology 2004 15 3 513 516 2-s2.0-1542378917 10.1097/01.ASN.0000115398.92270.30
4. Henry R. M. A., Kostense P. J., Bos G., Dekker J. M., Nijpels G., Heine R. J., Bouter L. M., Stehouwer C. D. A., Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn study. Kidney International 2002 62 4 1402 1407 2-s2.0-0036379472 10.1046/j.1523-1755.2002.00571.x
5. Ueda S., Yamagishi S.-I., Kaida Y., Okuda S., Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease. Nephrology 2007 12 6 582 590 2-s2.0-35848944105 10.1111/j.1440-1797. 2007.00840.x
6. Zoccali C., The endothelium as a target in renal diseases. Journal of Nephrology 2007 20 12 S39 S44 2-s2.0-39449084717
7. Ross R., Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999 340 24 1928 1929 2-s2.0-0033577954 10.1056/NEJM199906173402418
8. Wheeler D. C., Cardiovascular disease in patients with chronic renal failure. The Lancet 1996 348 9043 1673 1674 2-s2.0-0030444324 10.1016/S0140-6736(05)65816-3
9. Niwa T., Ise M., Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. Journal of Laboratory and Clinical Medicine 1994 124 1 96 104 2-s2.0-0028466186
10. Vanholder R., de Smet R., Pathophysiologic effects of uremic retention solutes. Journal of the American Society of Nephrology 1999 10 8 1815 1823 2-s2.0-0032838784
11. Dou L., Bertrand E., Cerini C., Faure V., Sampol J., Vanholder R., Berland Y., Brunet P., The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney International 2004 65 2 442 451 2-s2.0-1642480079 10.1111/j.1523-1755.2004.00399.x
12. Kobayashi N., Maeda A., Horikoshi S., Shirato I., Tomino Y., Ise M., Effects of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats. Nephron 2002 91 3 480 485 2-s2.0-0035996187 10.1159/000064291
13. Maeda K., Hamada C., Hayashi T., Shou I., Wakabayashi M., Fukui M., Horikoshi S., Tomino Y., Long-term effects of the oral adsorbent, AST-120, in patients with chronic renal failure. Journal of International Medical Research 2009 37 1 205 213 2-s2.0-64149095859
14. Yoshida Y., Sakai T., Ise M., Effects of oral adsorbent in the rat model of chronic renal failure. Nephron 1992 62 3 305 314 2-s2.0-0026648962
15. Otsuka A., Azuma K., Iesaki T., Sato F., Hirose T., Shimizu T., Tanaka Y., Daida H., Kawamori R., Watada H., Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta. Diabetologia 2005 48 12 2667 2674 2-s2.0-28444492667 10.1007/s00125-005-0005-6
16. Azuma K., Watada H., Niihashi M., Otsuka A., Sato F., Kawasumi M., Shimada S., Tanaka Y., Kawamori R., Mitsumata M., A new En face method is useful to quantitate endothelial damage in vivo. Biochemical and Biophysical Research Communications 2003 309 2 384 390 2-s2.0-0042889298 10.1016/j.bbrc.2003.08.013
17. Niwa T., Takeda N., Tatematsu A., Maeda K., Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clinical Chemistry 1988 34 11 2264 2267 2-s2.0-0024207828
18. Sanaka T., Funaki T., Tanaka T., Hoshi S., Niwayama J., Taitoh T., Nishimura H., Higuchi C., Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure. Nephron 2002 91 1 64 73 2-s2.0-0036092293 10.1159/000057606
19. Niwa T., Nomura T., Sugiyama S., Miyazaki T., Tsukushi S., Tsutsui S., The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney International 1997 51 62 S23 S28 2-s2.0-0030663544
20. Maeda K., Hamada C., Hayashi T., Shou I., Wakabayashi M., Fukui M., Horikoshi S., Tomino Y., Efficacy of adsorbent in delaying dialysis initiation among chronic kidney disease patients. Dialysis & Transplantation 2011 40 5 212 216 2-s2.0-79956031471 10.1002/dat.20569
21. Aoyama I., Shimokata K., Niwa T., An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron 2002 92 3 635 651 2-s2.0-0036357798
22. Günthner T., Jankowski V., Kretschmer A., Nierhaus M., Van Der Giet M., Zidek W., Jankowski J., Endothelium and vascular smooth muscle cells in the context of uremia. Seminars in Dialysis 2009 22 4 428 432 2-s2.0-69249104918 10.1111/j.1525-139X.2009.00594.x
23. Tepel M., Oxidative stress: does it play a role in the genesis of essential hypertension and hypertension of uraemia? Nephrology Dialysis Transplantation 2003 18 8 1439 1442 2-s2.0-0042164696 10.1093/ndt/gfg201
24. de Schutter T. M., Behets G. J., Geryl H., Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney International 2013 83 6 1109 1117 10.1038/ki.2013.34
25. Motojima K., Azuma K., Kitahara Y., Miura K., Mita T., Hirose T., Fujitani Y., Kawamori R., Watada H., Repetitive postprandial hypertriglyceridemia induces monocyte adhesion to aortic endothelial cells in Goto-Kakizaki rats. Endocrine Journal 2008 55 2 373 379 2-s2.0-43449094082 10.1507/endocrj.K07E-124
26. Nakagawa N., Hasebe N., Sumitomo K., Fujino T., Fukuzawa J., Hirayama T., Kikuchi K., An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats. American Journal of Nephrology 2006 26 5 455 461 2-s2.0-33845729891 10.1159/000096423
27. Lee S. H., Nam B. Y., Kang E. W., Han S. H., Li J. J., Kim D. H., Kim S. H., Kwak S.-J., Park J. T., Chang T. I., Yoo T.-H., Han D. S., Kang S.-W., Effects of an oral adsorbent on oxidative stress and fibronectin expression in experimental diabetic nephropathy. Nephrology Dialysis Transplantation 2010 25 7 2134 2141 2-s2.0-77954342329 10.1093/ndt/gfq063
28. Nakamura T., Kawagoe Y., Matsuda T., Ueda Y., Shimada N., Ebihara I., Koide H., Oral adsorbent AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure. Kidney and Blood Pressure Research 2004 27 2 121 126 2-s2.0-2342564944 10.1159/000077536